KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EBT (2012 - 2026)

AbbVie (ABBV) reported EBT of $1.0 billion for Q1 2026, down 37.45% year-over-year from $1.7 billion in Q1 2025, and down 61.06% on a QoQ basis from $2.7 billion in Q4 2025.

AbbVie (ABBV) has 15 years of EBT data on file, last reported at $1.0 billion in Q1 2026.

  • Quarterly EBT fell 37.45% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 billion (up 64.96% YoY) and the FY2025 annual result came in at $6.6 billion, up 77.53% from the prior year.
  • EBT fell to $1.0 billion in Q1 2026 per ABBV's latest filing, from $2.7 billion in the prior quarter.
  • Across five years, EBT topped out at $4.9 billion in Q1 2022 and bottomed at -$2.3 billion in Q4 2024.
  • The 5-year median for EBT is $1.8 billion (2024), against an average of $1.8 billion.
  • Peak annual rise in EBT reached 269.47% in 2024, while the deepest fall reached 287.21% in 2024.
  • Tracing ABBV's EBT over 5 years: stood at $3.0 billion in 2022, then sank by 59.12% to $1.2 billion in 2023, then slumped by 287.21% to -$2.3 billion in 2024, then jumped by 217.58% to $2.7 billion in 2025, then sank by 61.06% to $1.0 billion in 2026.
  • Per Business Quant, the three latest ABBV EBT figures stand at $1.0 billion (Q1 2026), $2.7 billion (Q4 2025), and $714.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 8.85 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 5.99 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 1.04 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -3.50 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 2.08 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 2.58 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 3.17 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 3.24 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.04 Bn
Dec 31, 2025 2.67 Bn
Sep 30, 2025 714.00 Mn
Jun 30, 2025 1.55 Bn
Mar 31, 2025 1.66 Bn
Dec 31, 2024 -2.27 Bn
Sep 30, 2024 2.08 Bn
Jun 30, 2024 2.15 Bn
Mar 31, 2024 1.76 Bn
Dec 31, 2023 1.21 Bn
Sep 30, 2023 1.95 Bn
Jun 30, 2023 2.61 Bn
Mar 31, 2023 475.00 Mn
Dec 31, 2022 2.97 Bn
Sep 30, 2022 4.40 Bn
Jun 30, 2022 1.18 Bn
Mar 31, 2022 4.93 Bn
Dec 31, 2021 4.27 Bn
Sep 30, 2021 3.69 Bn
Jun 30, 2021 1.16 Bn
Mar 31, 2021 3.87 Bn
Dec 31, 2020 -1.51 Bn
Sep 30, 2020 2.50 Bn
Jun 30, 2020 -693.00 Mn
Mar 31, 2020 3.10 Bn
Dec 31, 2019 3.07 Bn
Sep 30, 2019 2.00 Bn
Jun 30, 2019 807.00 Mn
Mar 31, 2019 2.54 Bn
Dec 31, 2018 -2.37 Bn
Sep 30, 2018 2.76 Bn
Jun 30, 2018 2.01 Bn
Mar 31, 2018 2.80 Bn
Dec 31, 2017 1.19 Bn
Sep 30, 2017 2.10 Bn
Jun 30, 2017 2.35 Bn
Mar 31, 2017 2.09 Bn
Dec 31, 2016 2.00 Bn
Sep 30, 2016 2.01 Bn
Jun 30, 2016 2.10 Bn
Mar 31, 2016 1.78 Bn
Dec 31, 2015 1.92 Bn
Sep 30, 2015 1.65 Bn
Jun 30, 2015 1.68 Bn
Mar 31, 2015 1.40 Bn
Dec 31, 2014 -1.04 Bn
Sep 30, 2014 687.00 Mn
Jun 30, 2014 1.43 Bn
Mar 31, 2014 1.29 Bn
Dec 31, 2013 1.44 Bn
Sep 30, 2013 1.29 Bn
Jun 30, 2013 1.37 Bn
Mar 31, 2013 1.24 Bn
Dec 31, 2012 1.71 Bn
Sep 30, 2012 1.60 Bn
Jun 30, 2012 1.40 Bn
Mar 31, 2012 1.01 Bn